Biodexa Pharmaceuticals plc - ADR

The momentum for this stock is not very good. Biodexa Pharmaceuticals plc - ADR is not a good value stock. Biodexa Pharmaceuticals plc - ADR is not a good growth stock. Biodexa Pharmaceuticals plc - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Biodexa Pharmaceuticals plc - ADR.
Log in to see more information.

News

Biodexa Pharmaceuticals Confronts Nasdaq Delisting
Biodexa Pharmaceuticals Confronts Nasdaq Delisting

TipRanks Financial Blog Biodexa Pharmaceuticals (BDRX) has released an update. Biodexa Pharmaceuticals PLC faces potential delisting from the Nasdaq Capital Market due to its stock price b...\n more…

Receipt of Nasdaq Delisting Determination - Plans to Appeal
Receipt of Nasdaq Delisting Determination - Plans to Appeal

Globe Newswire August 30, 2024 Biodexa Pharmaceuticals PLC( Biodexa or the Company )Receipt of Nasdaq Delisting Determination Plans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused...\n more…

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Up 63.4% in August
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Up 63.4% in August

Ticker Report Biodexa Pharmaceuticals Plc (NASDAQ:BDRX - Get Free Report) saw a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 104,400 shares, a growth...\n more…

Biodexa Pharmaceuticals files to sell 4.35B ordinary shares for holders
Biodexa Pharmaceuticals files to sell 4.35B ordinary shares for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement

Globe Newswire July 23, 2024 Biodexa Pharmaceuticals PLC Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals PLC ( Biodexa or the Company...\n more…

Biodexa Pharmaceuticals Unveils Series J Warrant
Biodexa Pharmaceuticals Unveils Series J Warrant

TipRanks Financial Blog Biodexa Pharmaceuticals (BDRX) has released an update. Biodexa Pharmaceuticals has announced a new Series J Warrant to purchase ordinary shares, exercisable from a ...\n more…